Literature DB >> 23400580

A meta-regression analysis of the available data on adherence to adjuvant hormonal therapy in breast cancer: summarizing the data for clinicians.

Laetitia Huiart, Cyril Ferdynus, Roch Giorgi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23400580     DOI： 10.1007/s10549-013-2422-4

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  29 in total

1.  Adherence to tamoxifen in breast cancer patients: What role does the pharmacist play in German primary care?

Authors:  Madlene Schulz; Lena Klopp-Schulze; Stefanie Keilhack; Sandra Meyer; Lea Botermann; Charlotte Kloft
Journal:  Can Pharm J (Ott)       Date:  2018-12-20

Review 2.  Behavioral Interventions to Enhance Adherence to Hormone Therapy in Breast Cancer Survivors: A Systematic Literature Review.

Authors:  Alejandra Hurtado-de-Mendoza; Mark L Cabling; Tania Lobo; Chiranjeev Dash; Vanessa B Sheppard
Journal:  Clin Breast Cancer       Date:  2016-03-31       Impact factor: 3.225

Review 3.  Future cancer research priorities in the USA: a Lancet Oncology Commission.

Authors:  Elizabeth M Jaffee; Chi Van Dang; David B Agus; Brian M Alexander; Kenneth C Anderson; Alan Ashworth; Anna D Barker; Roshan Bastani; Sangeeta Bhatia; Jeffrey A Bluestone; Otis Brawley; Atul J Butte; Daniel G Coit; Nancy E Davidson; Mark Davis; Ronald A DePinho; Robert B Diasio; Giulio Draetta; A Lindsay Frazier; Andrew Futreal; Sam S Gambhir; Patricia A Ganz; Levi Garraway; Stanton Gerson; Sumit Gupta; James Heath; Ruth I Hoffman; Cliff Hudis; Chanita Hughes-Halbert; Ramy Ibrahim; Hossein Jadvar; Brian Kavanagh; Rick Kittles; Quynh-Thu Le; Scott M Lippman; David Mankoff; Elaine R Mardis; Deborah K Mayer; Kelly McMasters; Neal J Meropol; Beverly Mitchell; Peter Naredi; Dean Ornish; Timothy M Pawlik; Jeffrey Peppercorn; Martin G Pomper; Derek Raghavan; Christine Ritchie; Sally W Schwarz; Richard Sullivan; Richard Wahl; Jedd D Wolchok; Sandra L Wong; Alfred Yung
Journal:  Lancet Oncol       Date:  2017-10-31       Impact factor: 41.316

Review 4.  Psychosocial factors in adjuvant hormone therapy for breast cancer: an emerging context for adherence research.

Authors:  Julia R Van Liew; Alan J Christensen; Janet S de Moor
Journal:  J Cancer Surviv       Date:  2014-07-02       Impact factor: 4.442

5.  Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials.

Authors:  Poornima Saha; Meredith M Regan; Olivia Pagani; Prudence A Francis; Barbara A Walley; Karin Ribi; Jürg Bernhard; Weixiu Luo; Henry L Gómez; Harold J Burstein; Vani Parmar; Roberto Torres; Josephine Stewart; Meritxell Bellet; Antonia Perelló; Faysal Dane; Antonio Moreira; Daniel Vorobiof; Michelle Nottage; Karen N Price; Alan S Coates; Aron Goldhirsch; Richard D Gelber; Marco Colleoni; Gini F Fleming
Journal:  J Clin Oncol       Date:  2017-06-27       Impact factor: 44.544

Review 6.  Interventions to improve endocrine therapy adherence in breast cancer survivors: what is the evidence?

Authors:  Ekim Ekinci; Salima Nathoo; Thushara Korattyil; Aisha Vadhariya; Hanna A Zaghloul; Polly A Niravath; Susan M Abughosh; Meghana V Trivedi
Journal:  J Cancer Surviv       Date:  2018-02-02       Impact factor: 4.442

7.  Use of hormonal therapy in senior breast cancer patients treated with or without radiotherapy.

Authors:  S P Krotneva; A Ramjaun; K E Reidel; T Eguale; N Trabulsi; N Mayo; R Tamblyn; A N Meguerditchian
Journal:  Curr Oncol       Date:  2014-02       Impact factor: 3.677

Review 8.  Local and Systemic Therapies for Breast Cancer Patients: Reducing Short-term Symptoms with the Methods of Integrative Medicine.

Authors:  C C Hack; P Voiß; S Lange; A E Paul; S Conrad; G J Dobos; M W Beckmann; S Kümmel
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-07       Impact factor: 2.915

9.  Barriers and facilitators to endocrine therapy adherence among underserved hormone-receptor-positive breast cancer survivors: a qualitative study.

Authors:  Kristen J Wells; Tonya M Pan; Coralia Vázquez-Otero; Danielle Ung; Amy E Ustjanauskas; Dariana Muñoz; Christine Laronga; Richard G Roetzheim; Marissa Goldenstein; Claudia Carrizosa; Sumayah Nuhaily; Kenneth Johnson; Marilyn Norton; Elizabeth Sims; Gwendolyn P Quinn
Journal:  Support Care Cancer       Date:  2016-05-05       Impact factor: 3.603

10.  Impact of patients' refusal to undergo adjuvant treatment measures on survival.

Authors:  H Männle; J W Siebers; F Momm; K Münstedt
Journal:  Breast Cancer Res Treat       Date:  2020-09-24       Impact factor: 4.872
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.